The main research areas of the group are:

• Molecular basis of de-regulated metabolism of cancer cells;
• Molecular basis of onset and reversion of chemoresistance in human tumors;
• Validation of new combinatorial antitumor therapies (e.g. dietary regimen; nutraceuticals -based chemotherapy; lipid metabolism modulatory drugs).